Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated October 29, 2024, please find enclosed the transcript of the Earnings Call for the Q2 FY25, held on Thursday, November 07, 2024, at 6.30 p.m. (IST).

pdf

Emcure Pharmaceuticals Ltd.

08 Nov 2024

1329.90

-1.63%

Earnings Call

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated October 29, 2024 regarding earnings call, the audio recording of the call held yesterday i.e. on November 07, 2024, is available on our website. The said audio recording can be accessed through the below web address: https://www.emcure.com/wp-content/uploads/2024/11/EMC0220241107156104.mp3

pdf

Emcure Pharmaceuticals Ltd.

29 Oct 2024

1329.90

-1.63%

Earnings Call

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform that the Earnings Call for Investors/ Analysts will be held on Thursday, November 07, 2024 at 6:30 p.m. (IST) to discuss the Company''s unaudited financial results (standalone and consolidated) and performance for the quarter ended September 30, 2024. The details of the aforesaid earnings call for Investors/Analysts is enclosed. The transcript and the audio recording of the Earnings Call will be made available on the Company's website and will be intimated accordingly.

pdf

Emcure Pharmaceuticals Ltd.

19 Aug 2024

1329.90

-1.63%

Earnings Call

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and further to our intimation dated August 8, 2024, please find enclosed the transcript of the Earnings Call for the Q1 FY25, held on Wednesday, August 14, 2024 at 8.30 a.m. (IST).

49.60% Gain from 52W Low

High vol. this week

Emcure Pharmaceuticals Ltd. Earnings/Conference Calls

Emcure Pharmaceuticals Ltd. earnings concalls and investor presentations